Primary Outcome Results of the Preventing Epilepsy Using Vigabatrin in Tuberous Sclerosis Complex Infants (PREVeNT Trial)

Authors

Darcy Krueger
Jurriaan Peters
Brenda Porter
Tarrant McPherson
Sarah O'Kelley
Mustafa Sahin
Katherine Taub
Rajesker Rajaraman
Stephanie Randle
Danielle Nolan, Beaumont Health

Document Type

Conference Proceeding

Publication Date

12-2-2023

Comments

American Epilepsy Society Annual Meeting, December 1-5, 2023, Orlando, FL

Recommended Citation

Krueger D, Peters J, Porter B, McPherson T, O'Kelley S, Sahin M, et al. [Nolan D]. Primary outcome results of the preventing epilepsy using vigabatrin in tuberous sclerosis complex infants (PREVeNT Trial). American Epilepsy Society Annual Conference; 2023 Dec 2; Orlando, FL. Available from: https://aesnet.org/abstractslisting/primary-outcome-results-of-the-preventing-epilepsy-using-vigabatrin-in-tuberous-sclerosis-complex-infants-prevent-trial